Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Accessibility StatementSkip Navigation SALT LAKE CITY, Sept. 9, 2025 /PRNewswire/ --Â Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that Co-Dxâ"¢ was an honoree at the Utah Business 2025 Innovation Awards Summit for the Co-Dx PCR platform*, in the Healthcare and Life Sciences category. Utah Business, a publication highlighting the ideas, innovations and people ...